Koyfin Home > Directory > Health Care > Abbvie Inc > Cost of Goods Sold

Abbvie Inc Cost of Goods Sold Chart (ABBV)

Abbvie Inc annual/quarterly Cost of Goods Sold from 2011 to 2020.
  • Abbvie Inc Cost of Goods Sold for the quarter ending September 09, 2020 was $5,028m a 60.10% increase of 3,022m year over year
  • Abbvie Inc Cost of Goods Sold for the last 12 months ending September 09, 2020 was $12,653m a 41.21% increase of 5,214m year over year
  • Abbvie Inc Annual Cost of Goods Sold for 2019 was $7,439m a -3.75% decrease of -279m from 2018
  • Abbvie Inc Annual Cost of Goods Sold for 2018 was $7,718m a 13.35% increase of 1,030m from 2017
  • Abbvie Inc Annual Cost of Goods Sold for 2017 was $6,688m a 13.38% increase of 895m from 2016
Other Income Statement Metrics:
  • Abbvie Inc EBITDA for the quarter ending December 12, 2018 was $3,371m a -4.87% decrease of -164m year over year
  • Abbvie Inc Net Income for the quarter ending December 12, 2018 was $-1,826m a 252.41% decrease of -4,609m year over year
  • Abbvie Inc Total Revenue for the quarter ending December 12, 2018 was $8,305m a 4.47% increase of 371m year over year
View Chart On Koyfin

Quarterly ABBV Cost of Goods Sold Data

09/2020$5,028m
06/2020$3,246m
03/2020$2,373m
12/2019$2,006m
09/2019$1,920m
06/2019$1,819m
03/2019$1,694m
12/2018$2,022m
09/2018$1,835m
06/2018$1,934m

Annual ABBV Cost of Goods Sold Data

2019$7,439m
2018$7,718m
2017$6,688m
2016$5,793m
2015$4,239m
2014$4,389m
2013$4,581m
2012$4,508m
2011$4,597m
2010$4,287m